title: Self-Assembling VHH-Elastin-Like Peptides for Photodynamic Nanomedicine.
abstract: Recombinant llama heavy-chain antibody fragments (VHHs) are promising tools in the field of targeted nanomedicine. 7D12, a VHH against the epidermal growth factor receptor (EGFR) that is overexpressed in various cancers, has been evaluated as an effective cancer-targeting VHH in multiple studies. The small size of VHHs (15-20 kDa) results in a low circulation half-life, which can be disadvantageous for certain applications. A solution to this problem is to attach VHHs to the surface of nanoparticles to increase the hydrodynamic radius of the conjugate. This approach simultaneously allows the incorporation of different VHHs and other targeting moieties and therapeutic components into one structure, creating multispecificity and versatility for therapy and diagnosis. Here, we present the construction of highly defined 7D12-containing nanoparticles by utilizing thermoresponsive diblock elastin-like peptides that reversibly self-assemble into micellar structures. The resulting particles have a hydrodynamic radius of 24.3 ± 0.9 nm and retain full EGFR-binding capacity. We present proof of concept of the usability of such particles by controlled incorporation of a photosensitizer and show that the resulting nanoparticles induce EGFR-specific light-induced cell killing. This approach is easily extended to the controlled incorporation of various functional modules, improving therapy and diagnosis with targeted nanomedicine.
authors.affiliation: Radboud University , Institute for Molecules and Materials, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.|Eindhoven University of Technology , Bio-organic Chemistry Lab, P.O. Box 513 (STO 3.31), 5600 MB Eindhoven, The Netherlands.
authors.forename: Jan
authors.initials: J
authors.lastname: Pille
authors.affiliation: Department of Pathology, Radboud University Medical Centre , Nijmegen, The Netherlands.
authors.forename: Sanne A M
authors.initials: SA
authors.lastname: van Lith
authors.affiliation: Radboud University , Institute for Molecules and Materials, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.|Eindhoven University of Technology , Bio-organic Chemistry Lab, P.O. Box 513 (STO 3.31), 5600 MB Eindhoven, The Netherlands.
authors.forename: Jan C M
authors.identifier: 0000-0001-7973-2404
authors.initials: JC
authors.lastname: van Hest
authors.affiliation: Department of Pathology, Radboud University Medical Centre , Nijmegen, The Netherlands.
authors.forename: William P J
authors.identifier: 0000-0003-0066-220X
authors.initials: WP
authors.lastname: Leenders
mesh_terms: D000818:Animals; D002161:Camelids, New World; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D004355:Drug Stability; D004549:Elastin / Q000737:chemistry*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics; D004926:Escherichia coli / Q000235:genetics; D006801:Humans; D008027:Light; D050997:Nanomedicine; D053758:Nanoparticles / Q000737:chemistry*; D010455:Peptides / Q000737:chemistry*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000737:chemistry*; D011993:Recombinant Fusion Proteins / Q000097:blood / Q000737:chemistry / Q000235:genetics / Q000494:pharmacology*; D061905:Single-Domain Antibodies / Q000737:chemistry*
chemical_list: D010455:Peptides; D017319:Photosensitizing Agents; D011993:Recombinant Fusion Proteins; D061905:Single-Domain Antibodies; D004549:Elastin; D066246:ErbB Receptors